MYND Life Sciences Financial Overview
MYND Life Sciences's market cap is currently $3.35M. The company's EPS TTM is C$; its P/E ratio is -5.88; MYND Life Sciences is scheduled to report earnings on June 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.